NO923533L - Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika - Google Patents

Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika

Info

Publication number
NO923533L
NO923533L NO92923533A NO923533A NO923533L NO 923533 L NO923533 L NO 923533L NO 92923533 A NO92923533 A NO 92923533A NO 923533 A NO923533 A NO 923533A NO 923533 L NO923533 L NO 923533L
Authority
NO
Norway
Prior art keywords
terminally
group
bonded
sulfo
amino acid
Prior art date
Application number
NO92923533A
Other languages
English (en)
Norwegian (no)
Other versions
NO923533D0 (no
Inventor
Marc Lang
Guido Bold
Alexander Faessler
Peter Schneider
Peter Van Hoogevest
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO923533D0 publication Critical patent/NO923533D0/no
Publication of NO923533L publication Critical patent/NO923533L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO92923533A 1991-09-12 1992-09-11 Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika NO923533L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH268991 1991-09-12
CH98092 1992-03-27
CH200792 1992-06-25

Publications (2)

Publication Number Publication Date
NO923533D0 NO923533D0 (no) 1992-09-11
NO923533L true NO923533L (no) 1993-03-15

Family

ID=27172572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923533A NO923533L (no) 1991-09-12 1992-09-11 Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika

Country Status (15)

Country Link
EP (1) EP0532466A3 (fi)
JP (1) JPH05230095A (fi)
KR (1) KR930006050A (fi)
AU (1) AU661018B2 (fi)
CA (1) CA2077948A1 (fi)
CZ (1) CZ280292A3 (fi)
FI (1) FI924035A (fi)
HU (1) HUT63632A (fi)
IL (1) IL103126A (fi)
MX (1) MX9205208A (fi)
NO (1) NO923533L (fi)
NZ (1) NZ244288A (fi)
PL (1) PL169969B1 (fi)
RU (1) RU2067585C1 (fi)
SK (1) SK280292A3 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
EP0633881B1 (en) * 1992-03-11 2003-10-29 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
TW217410B (fi) * 1992-04-01 1993-12-11 Ciba Geigy
ATE143004T1 (de) 1992-12-23 1996-10-15 Ciba Geigy Ag Antiretrovirale hydrazinderivate
EP0618222A3 (en) * 1993-03-11 1997-01-02 Ciba Geigy Ag Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
EP0626178A1 (de) * 1993-05-17 1994-11-30 Ciba-Geigy Ag Verwendung von Hemmstoffen von HIV-Aspartatproteasen zur Bekämpfung von Tumorerkrankungen
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
WO1996016980A1 (en) * 1994-11-29 1996-06-06 Novartis Ag Morpholinoethylamide derivatives
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
WO1997016188A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
CN1343219A (zh) * 1999-01-28 2002-04-03 中外制药株式会社 取代的苯乙基胺衍生物
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
KR100708221B1 (ko) 1999-08-31 2007-04-17 아지노모토 가부시키가이샤 에폭사이드 결정의 제조방법
JP4769400B2 (ja) 2000-01-19 2011-09-07 アボット・ラボラトリーズ 改良された医薬配合物
US6506786B2 (en) 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
AU2003290584B2 (en) * 2002-11-01 2009-07-16 Viropharma Incorporated Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
WO2007062526A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
CA2640435C (en) 2006-01-27 2011-11-01 Fibrogen, Inc. Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
WO2007115315A2 (en) 2006-04-04 2007-10-11 Fibrogen, Inc. Pyrrolo- and thiazolo-pyridine compounds as hif modulators
CN102083793A (zh) 2006-09-21 2011-06-01 安布林生物制药公司 蛋白酶抑制剂
JP5649584B2 (ja) 2008-11-14 2015-01-07 フィブロジェン インコーポレイテッド Ｈｉｆヒドロキシラーゼ阻害剤としてのチオクロメン誘導体
AU2014209319B2 (en) 2013-01-24 2018-04-19 Fibrogen, Inc. Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126326A (en) * 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives

Also Published As

Publication number Publication date
PL295905A1 (en) 1993-05-17
EP0532466A2 (de) 1993-03-17
FI924035A (fi) 1993-03-13
AU661018B2 (en) 1995-07-13
IL103126A0 (en) 1993-02-21
AU2288992A (en) 1993-03-18
RU2067585C1 (ru) 1996-10-10
FI924035A0 (fi) 1992-09-09
KR930006050A (ko) 1993-04-20
JPH05230095A (ja) 1993-09-07
HU9202925D0 (en) 1992-11-30
CA2077948A1 (en) 1993-03-13
EP0532466A3 (en) 1993-06-16
NO923533D0 (no) 1992-09-11
SK280292A3 (en) 1995-02-08
HUT63632A (en) 1993-09-28
NZ244288A (en) 1995-03-28
PL169969B1 (pl) 1996-09-30
IL103126A (en) 1997-09-30
MX9205208A (es) 1993-03-01
CZ280292A3 (en) 1994-01-19

Similar Documents

Publication Publication Date Title
NO923533L (no) Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika
YU66201A (sh) Derivati amina kao inhibitori proteaze
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
TW370529B (en) Pyrazolopyrimidines
DK436081A (da) Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
TW346485B (en) Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
NO20060703L (no) Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater
NO954975L (no) Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider
TW200745118A (en) Macrocylic inhibitors of hepatitis C virus
DK142084D0 (da) N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf
RS20050182A (en) Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics
WO2004052837A3 (en) Amino substituted hydroxyphenyl benzophenone derivatives
EP0353955A3 (en) Novel compounds
WO2003008379A1 (fr) Composes azasucre
MY103348A (en) Heteroaryl 3-0x0-propanenitrile derivatives and process for their preparation
CO4950567A1 (es) Inhibidores de proteasas dores de proteasas.
AU2003207432A1 (en) Urea linker derivatives for use as ppar modulators
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
EP0202062A3 (en) Quinuclidine derivatives
MX2007004482A (es) Derivados de piridina y la preparacion y el uso terapeutico de los mismos.
DK300890A (da) Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
DK492288A (da) Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne
TW333532B (en) Benzopyrans
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten